Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction.

Sabatine MS, Morrow DA, Higgins LJ, MacGillivray C, Guo W, Bode C, Rifai N, Cannon CP, Gerszten RE, Lee RT.

Circulation. 2008 Apr 15;117(15):1936-44. doi: 10.1161/CIRCULATIONAHA.107.728022. Epub 2008 Mar 31.

2.

ST2 in stable and unstable ischemic heart diseases.

Richards AM, Di Somma S, Mueller T.

Am J Cardiol. 2015 Apr 2;115(7 Suppl):48B-58B. doi: 10.1016/j.amjcard.2015.01.041. Epub 2015 Jan 23. Review.

PMID:
25678392
3.

Biomarker for the Prediction of Major Adverse Cardiac Events in Patients with Non-ST-Segment Elevation Myocardial Infarction.

Shon HS, Bae JW, Kim KO, Cha EJ, Kim KA.

Osong Public Health Res Perspect. 2017 Aug;8(4):237-246. doi: 10.24171/j.phrp.2017.8.4.02. Epub 2017 Aug 31. Review.

4.

ST2: a novel remodeling biomarker in acute and chronic heart failure.

Shah RV, Januzzi JL Jr.

Curr Heart Fail Rep. 2010 Mar;7(1):9-14. doi: 10.1007/s11897-010-0005-9. Review.

PMID:
20425491
5.

[Cardiac biomarkers in perioperative medicine : significance for noncardiac surgery patients].

Schlitt A, Reindl I, Ebelt H, Buerke M, Werdan K.

Anaesthesist. 2011 Aug;60(8):709-16. doi: 10.1007/s00101-011-1928-6. Review. German.

PMID:
21842250
6.

B-type natriuretic peptide in ischemic heart disease.

Deo R, de Lemos JA.

Curr Cardiol Rep. 2003 Jul;5(4):271-7. Review.

PMID:
12801444
7.

ST2 as a cardiovascular risk biomarker: from the bench to the bedside.

Januzzi JL Jr.

J Cardiovasc Transl Res. 2013 Aug;6(4):493-500. doi: 10.1007/s12265-013-9459-y. Epub 2013 Apr 5. Review.

PMID:
23558647
8.

Clinical Applications of Biomarkers in Atrial Fibrillation.

Chang KW, Hsu JC, Toomu A, Fox S, Maisel AS.

Am J Med. 2017 Dec;130(12):1351-1357. doi: 10.1016/j.amjmed.2017.08.003. Epub 2017 Aug 16. Review.

PMID:
28822701
9.

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis.

Merlini G, Lousada I, Ando Y, Dispenzieri A, Gertz MA, Grogan M, Maurer MS, Sanchorawala V, Wechalekar A, Palladini G, Comenzo RL.

Leukemia. 2016 Oct;30(10):1979-1986. doi: 10.1038/leu.2016.191. Epub 2016 Jul 15. Review.

10.

The search for efficient diagnostic and prognostic biomarkers of heart failure.

Emdin M, Mirizzi G, Pastormerlo LE, Poletti R, Giannelli E, Prontera C, Passino C, Vergaro G.

Future Cardiol. 2016 May;12(3):327-37. doi: 10.2217/fca.16.1. Epub 2016 Apr 19. Review.

PMID:
27092725
11.

Natriuretic peptide hormone measurement in acute coronary syndromes.

Maewal P, de Lemos JA.

Heart Fail Rev. 2003 Oct;8(4):365-8. Review.

PMID:
14574059
12.

Novel biomarkers predicting cardiac function after acute myocardial infarction.

Feistritzer HJ, Klug G, Reinstadler SJ, Reindl M, Mayr A, Mair J, Metzler B.

Br Med Bull. 2016 Sep;119(1):63-74. doi: 10.1093/bmb/ldw027. Epub 2016 Jul 14. Review.

PMID:
27418651
13.

Biomarkers for Heart Failure: An Update for Practitioners of Internal Medicine.

Wettersten N, Maisel AS.

Am J Med. 2016 Jun;129(6):560-7. doi: 10.1016/j.amjmed.2016.01.013. Epub 2016 Feb 1. Review.

PMID:
26844635
14.

[Biomarkers in cardiology--state of the art 2007].

Mair J.

Wien Med Wochenschr. 2007 Feb;157(3-4):48-56. Review. German.

PMID:
17340059
15.

Heart failure biomarkers: focus on interleukin-1 receptor-like 1-based blood tests.

Broch K, Ueland T, Yndestad A, Aukrust P, Gullestad L.

Drugs Today (Barc). 2012 Jul;48(7):479-91. doi: 10.1358/dot.2012.48.7.1811719. Review.

PMID:
22844659
16.

Clinical use of novel biomarkers in heart failure: towards personalized medicine.

Schmitter D, Cotter G, Voors AA.

Heart Fail Rev. 2014 May;19(3):369-81. doi: 10.1007/s10741-013-9396-5. Review.

PMID:
23709316
17.

Soluble ST2 in Heart Failure.

McCarthy CP, Januzzi JL Jr.

Heart Fail Clin. 2018 Jan;14(1):41-48. doi: 10.1016/j.hfc.2017.08.005. Review.

PMID:
29153199
18.

Mid-regional pro-adrenomedullin and ST2 in heart failure: Contributions to diagnosis and prognosis.

Lopes D, Menezes Falc√£o L.

Rev Port Cardiol. 2017 Jun;36(6):465-472. doi: 10.1016/j.repc.2016.11.009. Epub 2017 Jun 9. Review. English, Portuguese.

PMID:
28606358
19.

Inflammatory markers in ST-elevation acute myocardial infarction.

Seropian IM, Sonnino C, Van Tassell BW, Biasucci LM, Abbate A.

Eur Heart J Acute Cardiovasc Care. 2016 Aug;5(4):382-95. doi: 10.1177/2048872615568965. Epub 2015 Feb 13. Review.

PMID:
25681486
20.

Novel biomarkers for cardiovascular risk prediction.

Wang J, Tan GJ, Han LN, Bai YY, He M, Liu HB.

J Geriatr Cardiol. 2017 Feb;14(2):135-150. doi: 10.11909/j.issn.1671-5411.2017.02.008. Review.

Supplemental Content

Support Center